alexa
Reach Us +1-217-403-9671
Model-based Analysis Of The Relationship Between The Pharmacokinetics And Cerebral Perfusion Of Oxcarbazepine And Its Metabolite 10-monohydroxy Oxcarbazepine In Plasma Of Healthy Volunteers | 19816
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

5th World Congress on Bioavailability and Bioequivalence Pharmaceutical R&D Summit

Natal?cia de Jesus Antunes, Lauro Wichert-Ana, Vera Lucia Lanchote, Sven Van Dijkman, Johan G C Van Hasselt, Eduardo Barbosa Coelho, Veriano Alexandre Junior, Osvaldo Massaiti Takayanagui, Eduardo Tozatto, Maria Paula Marques and Oscar Della Pasqua
Accepted Abstracts: J Bioequiv Availab
DOI: 10.4172/0975-0851.S1.019
Abstract
O xcarbazepine (OXC) and its active metabolite 10-monohydroxy oxcarbazepine (MHD) enantiomers are P-glycoprotein (P-gp) substrates. This study aimed to evaluate the pharmacokinetic-pharmacodynamic relationship of OXC and MHD in the presence and absence of verapamil, a P-gp inhibitor. Healthy subjects (n=12) received for 5 days doses of 300 mg/12h OXC alone or combined with 80 mg/8 h verapamil. Blood samples were collected during 12 hours in conjunction with single-photon emission computed tomography for the assessment of drug concentrations and changes in cerebral perfusion. An integrated population pharmacokinetic model was developed using nonlinear mixed effects modelling, as implemented in NONMEM. A three-compartment model with first-order elimination and a set of transit compartments to describe the absorption profile best described the OXC pharmacokinetics. The MHD enantiomers disposition was characterised by one-compartment model. Clearance estimates (95% CI) was 84.9 L/h (69.5-100.3) for OXC and 2.0 L/h (1.9-2.1) for MHD. The volume of distribution was 131 L (97-165) for OXC, 23.6 L (14.4-32.8) for R-(-)- and 31.7 L (22.5-40.9) for S-(+)-MHD. Co-administration of verapamil was found to increase the bioavailability of OXC by 12% (10-28). This increase is most likely related to inhibition of P-gp in the intestinal tract. Based on allometric scaling from rat data, there appears to be a significant increase of R-(-)-MHD and S-(+)-MHD concentrations in the brain without clinically relevant changes to the circulating levels of either enantiomer. These estimates are in line with the changes in cerebral blood flow, as assessed by SPECT, which were observed after the verapamil co-administration
Biography
Natal?cia de Jesus Antunes has completed her Master degree at age 27 years from School of Pharmaceutical Sciences of Ribeir?o Preto, University of S?o Paulo. She is PhD student at the School of Pharmaceutical Sciences of Ribeir?o Preto, University of S?o Paulo. She did a PhD internship at the Division of Pharmacology, Leiden Academic Centre for Drug Research, Leiden University. She has worked with PK/PD modelling and pharmacokinetics studies of antihypertensive drugs during the pregnancy
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

streamtajm

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version